Table 2.
Fatty acids (percent of total FA) |
Serum PON1 activity |
P value | PON1/HDL-C ratio | P value | PON1/apo A-I ratio | P value |
---|---|---|---|---|---|---|
SFA | 0.097 | NS | 0.136 | NS | 0.109 | NS |
C14:0 (myristic acid) | 0.070 | NS | 0.190 | 0.028 | 0.123 | NS |
C16:0 (palmitic acid) | 0.029 | NS | 0.039 | NS | 0.037 | NS |
C18:0 (stearic acid) | 0.190 | 0.027 | 0.237 | 0.006 | 0.179 | 0.038 |
C20:0 (arachidic acid) | −0.064 | NS | 0.026 | NS | −0.004 | NS |
UFA | −0.097 | NS | −0.136 | NS | −0.109 | NS |
MUFA | 0.112 | NS | 0.111 | NS | 0.178 | 0.039 |
C14:1 (myristoleic acid) | −0.024 | NS | 0.034 | NS | 0.044 | NS |
C16:1 (palmitoleic acid) | 0.141 | NS | 0.157 | NS | 0.197 | 0.022 |
C18:1 (oleic acid) | 0.102 | NS | 0.095 | NS | 0.164 | NS |
PUFA | 0.057 | NS | −0.115 | NS | −0.107 | NS |
C18:3n3 (ALA) | −0.108 | NS | −0.070 | NS | −0.069 | NS |
C20:3n3 (ETE) | −0.052 | NS | 0.047 | NS | −0.059 | NS |
C20:5n3 (EPA) | −0.043 | NS | 0.124 | NS | 0.104 | NS |
C22:6n3 (DHA) | −0.037 | NS | 0.007 | NS | −0.020 | NS |
C18:2n6c (LA) | −0.100 | NS | −0.106 | NS | −0.133 | NS |
C20:3n6 (DGLA) | 0.260 | 0.002 | 0.257 | 0.003 | 0.278 | 0.001 |
C20:4n6 (AA) | 0.038 | NS | −0.075 | NS | −0.010 | NS |
| ||||||
SFA : UFA ratio | 0.097 | NS | 0.136 | NS | 0.109 | NS |
SFA : MUFA ratio | −0.074 | NS | −0.054 | NS | −0.134 | NS |
SFA : PUFA ratio | 0.077 | NS | 0.133 | NS | 0.111 | NS |
Total ω3 fatty acids | −0.047 | NS | 0.022 | NS | −0.010 | NS |
Total ω6 fatty acids | −0.111 | NS | −0.198 | 0.022 | −0.184 | 0.033 |
ω6 : ω3 ratio | −0.005 | NS | −0.088 | NS | −0.062 | NS |
AA : EPA ratio | −0.036 | NS | −0.148 | NS | −0.107 | NS |
EPA : DHA ratio | 0.054 | NS | 0.067 | NS | 0.084 | NS |
ALA: α-linolenic acid, ETE: eicosatrienoic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, LA: linoleic acid, DGLA: dihomo-gamma-linolenic acid, AA: arachidonic acid, SFA: saturated fatty acids, UFA: unsaturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids, NS: not significant.